Left ventricular assist devices: yesterday, today, and tomorrow

Athanasios Tsiouris; Mark S Slaughter; Ashok Kumar Coimbatore Jeyakumar; Adam N Protos

doi:10.1007/s10047-024-01436-0

Left ventricular assist devices: yesterday, today, and tomorrow

Athanasios Tsiouris
, Mark S Slaughter
, Ashok Kumar Coimbatore Jeyakumar
, Adam N Protos

Research output: Contribution to journal › Review article › peer-review

Abstract

The shortcomings of expense, power requirements, infection, durability, size, and blood trauma of current durable LVADs have been recognized for many years. The LVADs of tomorrow aspire to be fully implantable, durable, mitigate infectious risk, mimic the pulsatile nature of the native cardiac cycle, as well as minimize bleeding and thrombosis. Power draw, battery cycle lifespan and trans-cutaneous energy transmission remain barriers to completely implantable systems. Potential solutions include decreases in pump electrical draw, improving battery lifecycle technology and better trans-cutaneous energy transmission, potentially from Free-range Resonant Electrical Energy Delivery. In this review, we briefly discuss the history of LVADs and summarize the LVAD devices in the development pipeline seeking to address these issues.

Original language	English
Pages (from-to)	335-344
Number of pages	10
Journal	Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
Volume	27
Issue number	4
DOIs	https://doi.org/10.1007/s10047-024-01436-0
State	Published - Dec 2024
Externally published	Yes

Keywords

Heart-Assist Devices/trends
Humans
Heart Failure/therapy
History, 20th Century
History, 21st Century

Access to Document

10.1007/s10047-024-01436-0

Cite this

@article{df84710123c04355a7e210ef34412425,

title = "Left ventricular assist devices: yesterday, today, and tomorrow",

abstract = "The shortcomings of expense, power requirements, infection, durability, size, and blood trauma of current durable LVADs have been recognized for many years. The LVADs of tomorrow aspire to be fully implantable, durable, mitigate infectious risk, mimic the pulsatile nature of the native cardiac cycle, as well as minimize bleeding and thrombosis. Power draw, battery cycle lifespan and trans-cutaneous energy transmission remain barriers to completely implantable systems. Potential solutions include decreases in pump electrical draw, improving battery lifecycle technology and better trans-cutaneous energy transmission, potentially from Free-range Resonant Electrical Energy Delivery. In this review, we briefly discuss the history of LVADs and summarize the LVAD devices in the development pipeline seeking to address these issues.",

keywords = "Heart-Assist Devices/trends, Humans, Heart Failure/therapy, History, 20th Century, History, 21st Century",

author = "Athanasios Tsiouris and Slaughter, \{Mark S\} and Jeyakumar, \{Ashok Kumar Coimbatore\} and Protos, \{Adam N\}",

note = "{\textcopyright} 2024. The Japanese Society for Artificial Organs.",

year = "2024",

month = dec,

doi = "10.1007/s10047-024-01436-0",

language = "English",

volume = "27",

pages = "335--344",

journal = "Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs",

issn = "1434-7229",

number = "4",

}

TY - JOUR

T1 - Left ventricular assist devices

T2 - yesterday, today, and tomorrow

AU - Tsiouris, Athanasios

AU - Slaughter, Mark S

AU - Jeyakumar, Ashok Kumar Coimbatore

AU - Protos, Adam N

PY - 2024/12

Y1 - 2024/12

N2 - The shortcomings of expense, power requirements, infection, durability, size, and blood trauma of current durable LVADs have been recognized for many years. The LVADs of tomorrow aspire to be fully implantable, durable, mitigate infectious risk, mimic the pulsatile nature of the native cardiac cycle, as well as minimize bleeding and thrombosis. Power draw, battery cycle lifespan and trans-cutaneous energy transmission remain barriers to completely implantable systems. Potential solutions include decreases in pump electrical draw, improving battery lifecycle technology and better trans-cutaneous energy transmission, potentially from Free-range Resonant Electrical Energy Delivery. In this review, we briefly discuss the history of LVADs and summarize the LVAD devices in the development pipeline seeking to address these issues.

AB - The shortcomings of expense, power requirements, infection, durability, size, and blood trauma of current durable LVADs have been recognized for many years. The LVADs of tomorrow aspire to be fully implantable, durable, mitigate infectious risk, mimic the pulsatile nature of the native cardiac cycle, as well as minimize bleeding and thrombosis. Power draw, battery cycle lifespan and trans-cutaneous energy transmission remain barriers to completely implantable systems. Potential solutions include decreases in pump electrical draw, improving battery lifecycle technology and better trans-cutaneous energy transmission, potentially from Free-range Resonant Electrical Energy Delivery. In this review, we briefly discuss the history of LVADs and summarize the LVAD devices in the development pipeline seeking to address these issues.

KW - Heart-Assist Devices/trends

KW - Humans

KW - Heart Failure/therapy

KW - History, 20th Century

KW - History, 21st Century

U2 - 10.1007/s10047-024-01436-0

DO - 10.1007/s10047-024-01436-0

M3 - Review article

C2 - 38451441

SN - 1434-7229

VL - 27

SP - 335

EP - 344

JO - Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs

JF - Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs

IS - 4

ER -